-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(S)-trans-2-Amino-4-(2-aminoethoxy)-3-butenoic acid hydrochloride, also known as Linezolid, is an antibiotic agent used to treat various bacterial infections.
The synthesis of Linezolid involves several steps, and there are several synthetic routes that can be used to synthesize this compound.
In this article, we will discuss some of the most common synthetic routes for Linezolid and their significance in the chemical industry.
One of the most common synthetic routes for Linezolid involves the reduction of N-phenylanthranilic acid to form N-phenyl-2-aminothiazolidine-4-carboxylic acid.
This step is followed by the nucleophilic substitution of the carboxylic acid with 2-amino-4-(2-aminoethoxy)-3-butenoic acid to form the desired compound.
This route is a multi-step process that requires the use of several chemical reagents and solvents, but it is widely used due to its high yield and cost-effectiveness.
Another synthetic route for Linezolid involves the use of a "one-pot" reaction, where the N-phenylanthranilic acid is treated with 2-amino-4-(2-aminoethoxy)-3-butenoic acid and several other reagents in the presence of a base.
This reaction results in the formation of the desired compound, as well as the concurrent formation of the byproduct N-phenyl-2-aminothiazolidine-4-carboxylic acid.
This route is more efficient than the multi-step process described above, as it combines several steps into a single reaction, making it easier to scale up and more cost-effective.
There are also several other synthetic routes for Linezolid, including those that involve the use of enzymes or biotechnology.
For example, one route involves the use of a whole-cell biocatalyst that employs a bacterial strain to convert N-phenylanthranilic acid to Linezolid.
This route is more environmentally friendly, as it does not require the use of toxic chemical reagents, but it is currently less cost-effective than the chemical synthesis routes.
In summary, there are several synthetic routes for Linezolid, each with its own advantages and disadvantages.
The most commonly used routes involve the reduction of N-phenylanthranilic acid to form N-phenyl-2-aminothiazolidine-4-carboxylic acid, followed by nucleophilic substitution with 2-amino-4-(2-aminoethoxy)-3-butenoic acid.
Other routes involve the use of one-pot reactions or enzymes, and each route has its own advantages and limitations.
Ultimately, the choice of synthetic route for Linezolid will depend on the specific needs of the chemical industry and the desired cost and efficiency trade-offs.